AMBER RAY: Open Payments
NPI 1881394526 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 13 payments from 8 companies in 2025. Trend: 2023 $210 · 2024 $419 · 2025 $350
Food & beverage: $250Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $212 |
| Biogen, Inc. | 1 | $25 |
| Organon LLC | 1 | $24 |
| Exeltis, USA Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Veozah, ZURZUVAE, NEXPLANON, SLYND, Mirena, MYFEMBREE, MOUNJARO.
Industry payments across AR — which companies pay providers there.
